Wordt geladen...
Patient Cost Sharing and Receipt of Erythropoiesis-Stimulating Agents Through Medicare Part D
PURPOSE: Medicare Part D prescription benefits cover injected medications, normally covered under Part B, when administered outside of physician offices. Erythropoiesis-stimulating agents (ESAs) used for chronic anemia management in patients with myelodysplastic syndromes (MDS) are commonly injected...
Bewaard in:
| Gepubliceerd in: | J Oncol Pract |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Clinical Oncology
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4371123/ https://ncbi.nlm.nih.gov/pubmed/25563701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2014.001527 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|